In March 2020, Zeposia secured its first regulatory approval for relapsing forms of Multiple Sclerosis. These T-Cells target and destroy any abnormal cells, including cancer cells. Abecma was being developed by Bristol Myers Squibb and bluebird bio Inc. CAR-T therapy refers to extraction of a patients own T cells, which are then genetically modified and infused back into the patients body. 2020 Coronavirus CrisisTimeline of 2020 Crisis So Far:12/12/2019: Coronavirus cases first reported in China1/31/2020: WHO declares a global health emergency. After the multiple myeloma CAR-T therapy approval, eyes will now be on the FDAs decision regarding Opdivos use for additional indications, as well as Zeposia in ulcerative colitis.
the first ever out of their eyes is chinese approved multiple times by the society.
( z0 person :quant ( z1 out-of :op ( z2 eye :part-of ( z3 they ) ) ) :ARG1-of ( z4 approve :ARG0 ( z5 society ) :frequency ( z6 multiple ) ) :mod ( z7 country :name ( z8 name :op "China" ) ) :ord ( z9 ordinal-entity :value 1 ) :rel ( z10 ever ) )
(z0 / person
    :quant (z1 / out-of
               :op1 (z2 / eye
                        :part-of (z3 / they)))
    :ARG1-of (z4 / approve-01
                 :ARG0 (z5 / society)
                 :frequency (z6 / multiple))
    :mod (z7 / country
             :name (z8 / name
                       :op1 "China"))
    :ord (z9 / ordinal-entity
             :value 1)
    :rel (z10 / ever))
the first ever out of their eyes is chinese approved multiple times by the society .
z9 :value 0
z2 :part-of z3
z1 :op1 z2
z0 :quant z1
z0 :ord z9
z0 :mod z7
z7 :name z8
z8 :op1 1
z0 :ARG1-of z4
z4 :frequency z6
z4 :ARG0 z5
z0 :rel z10